FeesSafety
Pluang+

Black Hills raises dividend for 56 years, merger with Northwestern Energy nears final approval.

Market News
03 Oct 2026
Seeking Alpha
View Source
Bullish
Black Hills raises dividend for 56 years, merger with Northwestern Energy nears final approval.

Black Hills has increased its dividend for 56 consecutive years, earning it the title of Dividend King. The company is close to completing its merger with Northwestern Energy, with only one regulatory approval remaining. Black Hills holds a strong BBB+ credit rating and its shares are currently trading at a 7% discount to fair value. This positions the stock to potentially deliver 10% annual total returns through 2031.

Black Hills stock is the subject, with Pluang's Utilities sector data providing market context as of Oct 03, 2026 18:01 WIB. For readers following Utilities, here is Pluang's market snapshot: of 22 priced US Utilities stocks tradable on Pluang, 13 rose and 9 fell today. Notable movers include Constellation Energy Corporation (CEG) at USD 257.49 with a 0.55% decrease and a typical hold time of 40 days, Entergy Corporation (ETR) at USD 100.91 with a 0.51% increase and a typical hold time of 8 days, and Atmos Energy Corporation (ATO) at USD 157.17 with a 0.51% increase and a typical hold time of 51 days. The most notable figure is Pluang order activity for CEG at 1% Sell / 99% Buy.

More News

Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...

Company Fundamentals
Bullish
49 minutes ago
Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...

Company Fundamentals
Bullish
49 minutes ago
Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...

Market News
Bullish
49 minutes ago
eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...

Others
Neutral
1 hour ago
Balchem posts Q3 2026 sales of $290.7M, net earnings up 16%, driven by growth in all segments.

Balchem posts Q3 2026 sales of $290.7M, net earnings up 16%, driven by growth in all segments.

Balchem Corporation reported strong Q3 2026 results with net sales of $290.7 million, up 8.6% year-over-year, and net earnings of $46.7 million, a 16% increase. Growth was driven by all three segments: Human Nutrition and Health, Animal Nutrition and...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App